What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030?

F1000Research
Anthony D HarriesPiero Olliaro

Abstract

The international community has committed to ending the tuberculosis (TB) epidemic by 2030. This will require multi-sectoral action with a focus on accelerating socio-economic development, developing and implementing new tools, and expanding health insurance coverage. Within this broad framework, National TB Programmes (NTPs) are accountable for delivering diagnostic, treatment, and preventive services. There are large gaps in the delivery of these services, and the aim of this article is to review the crucial activities and interventions that NTPs must implement in order to meet global targets and milestones that will end the TB epidemic. The key deliverables are the following: turn End TB targets and milestones into national measurable indicators to make it easier to track progress; optimize the prompt and accurate diagnosis of all types of TB; provide rapid, complete, and effective treatment to all those diagnosed with TB; implement and monitor effective infection control practices; diagnose and treat drug-resistant TB, associated HIV infection, and diabetes mellitus; design and implement active case finding strategies for high-risk groups and link them to the treatment of latent TB infection; engage with the private-for-pro...Continue Reading

References

Nov 13, 2004·BMJ : British Medical Journal·Anthony D HarriesRex Mpazanje
Apr 22, 2006·Bulletin of the World Health Organization·Edwin LibambaAnthony D Harries
Jan 19, 2007·Clinical Medicine : Journal of the Royal College of Physicians of London·Guy Thwaites
Aug 30, 2007·The Journal of Infectious Diseases·Naomi N BockEdward Nardell
Dec 18, 2007·Chronic Illness·Catherine R StevensonNigel C Unwin
Apr 29, 2008·Bulletin of the World Health Organization·Simon D MakombeAnthony D Harries
Mar 4, 2009·Pediatrics·S Maria E FinnellStephen M Downs
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea A Howard, Wafaa M El-Sadr
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Sep 10, 2010·The New England Journal of Medicine·Catharina C BoehmeMark D Perkins
Jan 5, 2011·PLoS Medicine·Iacopo BaussanoFabio Scano
Mar 17, 2011·Diabetes Technology & Therapeutics·Courtney Rees LylesJames D Ralston
Jul 5, 2011·BMC Medicine·Meghan A BakerMegan B Murray
Jul 16, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S D LawnR Wood
Oct 19, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A TrébucqH L Rieder
Jun 5, 2012·Transactions of the Royal Society of Tropical Medicine and Hygiene·F K AfutuA D Harries
Jul 27, 2012·Tropical Medicine & International Health : TM & IH·Liang LiAnthony D Harries
Jul 27, 2012·Tropical Medicine & International Health : TM & IH·Yan LinAnthony D Harries
Sep 1, 2012·The European Respiratory Journal·Gregory J FoxGuy B Marks
Feb 15, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·K LönnrothM Raviglione
Mar 2, 2013·Tropical Medicine & International Health : TM & IH·UNKNOWN India Diabetes Mellitus--Tuberculosis Study Group
Mar 6, 2013·Tropical Medicine & International Health : TM & IH·UNKNOWN India Tuberculosis-Diabetes Study Group
Mar 8, 2013·PloS One·George W ReedHardy Kornfeld
Sep 5, 2014·JAMA : the Journal of the American Medical Association·Thomas R FriedenAnthony D Harries
Dec 30, 2014·The Lancet Global Health·Alimuddin ZumlaMatt Oliver
May 13, 2015·The Indian Journal of Medical Research·Madhukar Pai
May 29, 2015·The New England Journal of Medicine·Haileyesus GetahunMario Raviglione
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN TEMPRANO ANRS 12136 Study GroupXavier Anglaret

❮ Previous
Next ❯

Citations

Mar 17, 2019·Tropical Medicine and Infectious Disease·Anthony D HarriesRony Zachariah
Jun 4, 2019·International Journal for Equity in Health·Camila GianellaClaudia Lema
Jun 3, 2021·Cadernos de saúde pública·Nelson Enrique Arenas-SuarezAndrea Clemencia Pineda-Peña
Aug 25, 2021·BMC Health Services Research·Rita Suhuyini Salifu, Khumbulani W Hlongwana

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleic acid amplification

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Transactions of the Royal Society of Tropical Medicine and Hygiene
Anthony D HarriesAnil Kapur
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S RosalesS E Hoffner
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
A B SutharAnthony D Harries
© 2022 Meta ULC. All rights reserved